"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 14 | 14 |
| 2007 | 0 | 11 | 11 |
| 2008 | 0 | 11 | 11 |
| 2009 | 1 | 11 | 12 |
| 2010 | 1 | 11 | 12 |
| 2011 | 0 | 8 | 8 |
| 2012 | 0 | 14 | 14 |
| 2013 | 3 | 15 | 18 |
| 2014 | 2 | 17 | 19 |
| 2015 | 2 | 26 | 28 |
| 2016 | 0 | 12 | 12 |
| 2017 | 3 | 24 | 27 |
| 2018 | 5 | 23 | 28 |
| 2019 | 3 | 29 | 32 |
| 2020 | 0 | 24 | 24 |
| 2021 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
The intersection of COVID-19 and autoimmunity. J Clin Invest. 2021 12 15; 131(24).
-
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study. Gynecol Oncol. 2021 11; 163(2):392-397.
-
Outcome measures assisting treatment optimization in multiple sclerosis. J Neurol. 2022 Mar; 269(3):1282-1297.
-
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
-
Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course. J Cutan Pathol. 2021 Sep; 48(9):1166-1172.
-
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. Neurology. 2021 05 04; 96(18):e2296-e2312.
-
A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 03 23; 77(11):1470-1479.
-
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis. Hepatology. 2021 04; 73(4):1290-1306.
-
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers. J Autoimmun. 2021 05; 119:102615.
-
Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data. PLoS One. 2021; 16(2):e0247233.